Clinical Trial: Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06873737) titled 'Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker' on March 05.

Brief Summary: Analysis of the circulating levels of placenta-derived HLA-DR+ extracellular vesicles in the first, second and third trimester of pregnancy of women with high and low risk to develop preeclampsia.

Study Start Date: Sept. 01, 2022

Study Type: INTERVENTIONAL

Condition: Preeclampsia

Intervention: OTHER: Blood samples for inflammatory markers

Blood sampling in the first, second, trimester of pregnancy

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Fondazione Policlinico Universitari...